Overview

Study of AS1411 in Advanced Solid Tumours

Status:
Completed
Trial end date:
2007-02-01
Target enrollment:
Participant gender:
Summary
A Phase I open label study of AS1411 in advanced solid tumours. Objectives include determining the MTD and DLT of AS1411, to determine the PK profile of AS1411 and to obtain preliminary evidence of clinical and biological responses to AS1411 therapy.
Phase:
Phase 1
Details
Lead Sponsor:
Antisoma Research